A Study for Patients With Multiple Sclerosis

NCT00870155 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

TERMINATED

Status

546

Enrollment

INDUSTRY

Sponsor class

Stopped Negative efficacy results of the MAESTRO-01 trial

Conditions

Secondary Progressive Multiple Sclerosis

Interventions

DRUG: dirucotide

Sponsor

Eli Lilly and Company

Collaborators

[object Object]